Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Cruikshank
David Cruikshank, Delafield, WI US
| Patent application number | Description | Published |
|---|---|---|
| 20090243238 | SKATE BOOT - A skate boot includes a foot portion configured to receive and secure a foot of a wearer. The skate boot includes a first tendon guard positioned proximal an Achilles tendon of a wearer of the skate boot, the first tendon guard being connected to the foot portion at a first articulation point and adjacent the foot portion along a medial abutment line and a lateral abutment line. The skate boot may optionally include a second tendon guard connected to the foot portion at a second articulation point and to the first tendon guard, the second tendon guard covering the first articulation point. In at least one embodiment, an elastomeric band is connected to the foot portion and to the first tendon guard and configured to bias the first tendon guard to a closed position. In at least one embodiment, an electrical generator is provided to heat an ice skate interconnected to the boot. | 10-01-2009 |
| 20110101665 | HOCKEY SKATE - A skate assembly includes a shell structure and a removable tendon guard. The shell structure includes a heel portion, a lateral ankle portion, and a medial ankle portion. The heel portion is formed to cover a human heel. The lateral ankle portion is formed to extend beyond the heel portion. The medial ankle portion is formed to extend beyond the heel portion. The lateral ankle portion and the medial ankle portion are spaced apart to form a notch extending toward the heel portion. The removable tendon guard is removably attached between the lateral ankle portion and medial ankle portion to cover the notch. | 05-05-2011 |
Greg Cruikshank, Sunnydale, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110229565 | Drug Delivery Composition Comprising a Self-Assembled Gelator - This invention discloses drug-delivery compositions, methods of making prodrugs, and methods of drug delivery using a self-assembled gelator. The backbone of the gelator can contain a drug or prodrug, such as acetaminophen or salicin. Additional drugs or agents can be encapsulated in the gelator. Enzymatic or hydrolytic cleavage can be used to release the drugs. | 09-22-2011 |
John Cruikshank, Brisbane AU
| Patent application number | Description | Published |
|---|---|---|
| 20080236439 | SEMI-RIGID RAILCAR COVER - A cover for open top railcars may be alternatively locked into place over the railcar top opening, or rotated on hinges to either side of the railcar to provide access to the entire top of the railcar. The cover may be compressed against either side of the railcar to allow the car to move between structural or other elements of loading or unloading facilities. | 10-02-2008 |
William W. Cruikshank, Westford, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100008936 | IL-16 antagonist peptides and DNA encoding the peptides - The present invention has found that a series of peptides having sequences that substantially correspond to specific regions of the C-terminus of IL-16 can inhibit the activity of IL-16. The present invention has demonstrated that such IL-16-inhibiting peptides can be as short as 4 amino acids in length. Based on these discoveries, the present invention provides IL-16 antagonist peptides and the use thereof for the treatment of IL-16 mediated disorders such as certain inflammatory diseases. | 01-14-2010 |
| 20110123526 | METHODS AND COMPOSITIONS FOR PREVENTING ADHESION - This invention provides methods and compositions for preventing post-surgical adhesion formation based on use of an interleukin-16 (IL-16) antagonist, including an IL-16 antagonist peptide and/or an IL-16 antagonist antibody. | 05-26-2011 |
| 20110207679 | METHODS OF TREATMENT USING IL-16 ANTAGONIST PEPTIDES - The present invention has found that a series of peptides having sequences that substantially correspond to specific regions of the C-terminus of IL-16 can inhibit the activity of IL-16. The present invention has demonstrated that such IL-16-inhibiting peptides can be as short as 4 amino acid in length. Based on these discoveries, the present invention provides IL-16 antagonist peptides and the use thereof for the treatment of IL-16 mediated disorders such as certain inflammatory diseases. | 08-25-2011 |